Blood Sugar Monitoring in Critically Ill Patients: Risks & Management
Critically ill patients face high risk of both hyperglycemia and hypoglycemia, each carrying serious consequences. Vigilant glucose monitoring is essential.
Hyperglycemia in Critical Illness
Causes:
- Stress response: cortisol, catecholamines, glucagon ↑ → gluconeogenesis, insulin resistance
- Exogenous glucose: IV fluids, nutrition, medications
- Medication effects: steroids, vasopressors
Consequences: Infection risk ↑, wound healing delayed, organ dysfunction, mortality ↑
Hypoglycemia in Critical Illness
Causes:
- Impaired oral intake
- Insulin/insulin secretagogues
- Liver/kidney dysfunction impairing gluconeogenesis
- Sepsis, adrenal insufficiency
Consequences: Seizures, coma, neurological injury, death
Evidence-Based Targets & Monitoring
- Target range: 140–180 mg/dL (per ADA/SCCM guidelines)
- Frequency: q1–2h for high-risk (insulin infusion, unstable); q4h for stable
- Methods: Arterial line (gold standard), capillary (point-of-care), continuous glucose monitoring (emerging)
- Who monitors: ICU nurses, physicians, pharmacists (protocol-driven)
Protocolized insulin therapy with frequent monitoring reduces both hyper- and hypoglycemia, improving outcomes.
Diabetes - Related Articles
- Blood Sugar Support: Nutritional Supplements for Balanced Levels
- Diabetes Diet: Foods to Eat for Blood Sugar Control
- Insulin Pump Costs: A Comprehensive Price Comparison Guide
- Colon Obstruction & Diabetes: Understanding the Connection & Relief
- Understanding Sugar Content vs. Glycemic Index: A Comprehensive Guide
- Barefoot Walking: Can It Make You Sick?
- Diabetes Diagnosis: Understanding Confirmation Methods
